These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34621141)

  • 21. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up.
    Pinto RJ; Dalvi BV; Sharma S
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):145-52. PubMed ID: 16763998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Off-label use of duct occluder devices to close hemodynamically significant perimembranous ventricular septal defects: A multicenter experience.
    Udink Ten Cate FEA; Sobhy R; Kalantre A; Sachdev S; Subramanian A; Koneti NR; Kumar RK; Hamza H; Jayranganath M; Sreeram N
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):82-88. PubMed ID: 30208249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Device Closure of Perimembranous Ventricular Septal Defect: Choosing Between Amplatzer Occluders.
    Haddad RN; Daou L; Saliba Z
    Front Pediatr; 2019; 7():300. PubMed ID: 31475122
    [No Abstract]   [Full Text] [Related]  

  • 24. Transcatheter closure of a perimembranous ventricular septal defect with Nit-Occlud Lê VSD Coil: A French multicentre study.
    Houeijeh A; Godart F; Jalal Z; Ovaert C; Heitz F; Mauran P; Baruteau AE; Guirguis L; Hadeed K; Baudelet JB; Iriart X; Aldebert P; Acar P; Fraisse A; Odemis E; Karsenty C; Thambo JB; Hascoët S
    Arch Cardiovasc Dis; 2020 Feb; 113(2):104-112. PubMed ID: 31982353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arrhythmias after transcatheter closure of perimembranous ventricular septal defects with a modified double-disk occluder: early and long-term results.
    Li P; Zhao XX; Zheng X; Qin YW
    Heart Vessels; 2012 Jul; 27(4):405-10. PubMed ID: 21643813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry.
    Holzer R; de Giovanni J; Walsh KP; Tometzki A; Goh T; Hakim F; Zabal C; de Lezo JS; Cao QL; Hijazi ZM
    Catheter Cardiovasc Interv; 2006 Oct; 68(4):620-8. PubMed ID: 16969878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitral and aortic valve regurgitation following surgical and transcatheter perimembranous ventricular septal defect closure in children and adolescents: midterm outcomes.
    Edraki M; Nobakhti M; Naghshzan A; Amoozgar H; Amirghofran A; Ghasemzadeh B; Nirooie E; Mehdizadegan N; Mohammadi H; Keshavarz K
    BMC Cardiovasc Disord; 2022 Jul; 22(1):315. PubMed ID: 35840901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcatheter Closure of Perimembranous Ventricular Septal Defects with Left Ventricular to Right Atrial Shunt.
    Kerst G; Moysich A; Ho SY; Apitz C; Latus H; Schranz D
    Pediatr Cardiol; 2015 Oct; 36(7):1386-92. PubMed ID: 25894760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perimembranous Ventricular Septal Defect Device Closure: Choosing Between Amplatzer Duct Occluder I and II.
    El-Sisi A; Sobhy R; Jaccoub V; Hamza H
    Pediatr Cardiol; 2017 Mar; 38(3):596-602. PubMed ID: 28251252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very late-onset endocarditis complicated by non-significant aortic regurgitation after device closure of perimembranous ventricular septal defect.
    Tang C; Zhou K; Hua Y; Wang C
    Medicine (Baltimore); 2020 May; 99(19):e20120. PubMed ID: 32384490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Efficacy and Medium to Long-Term Follow-Up of Transcatheter Retrograde Closure of Perimembranous Ventricular Septal Defects via the Femoral Artery With Amplatzer Duct Occluder II in Children.
    Jiang D; Zhang J; Fan Y; Han B; Zhao L; Yi Y; Lv J; Wang J
    Front Pediatr; 2021; 9():571407. PubMed ID: 34113582
    [No Abstract]   [Full Text] [Related]  

  • 32. Midterm Results of Transaxillary Occluder Device Closure of Perimembranous Ventricular Septal Defect Guided Solely by Transesophageal Echocardiography.
    Liang W; Zhou S; Fan T; Song S; Li B; Dong H; Zhang L; Hu M; Liu L
    Heart Surg Forum; 2019 Mar; 22(2):E112-E118. PubMed ID: 31013220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter closure of perimembranous ventricular septal defects in infants and children using the Amplatzer perimembranous ventricular septal defect occluder.
    Thanopoulos BV; Rigby ML; Karanasios E; Stefanadis C; Blom N; Ottenkamp J; Zarayelyan A
    Am J Cardiol; 2007 Apr; 99(7):984-9. PubMed ID: 17398197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter closure of perimembranous ventricular septal defects with ductal occluders.
    Mahimarangaiah J; Subramanian A; Kikkeri Hemannasetty S; Chandra S; Karur S; Mandikal Kodandaramasastry U; Cholenahally Nanjappa M
    Cardiol Young; 2015 Jun; 25(5):918-26. PubMed ID: 25022868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter closure of ventricular septal defect in aortic valve prolapse and aortic regurgitation.
    Ghosh S; Sridhar A; Solomon N; Sivaprakasham M
    Indian Heart J; 2018; 70(4):528-532. PubMed ID: 30170648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follow-up of patients with interventional closure of ventricular septal defects with Amplatzer Duct Occluder II.
    Kanaan M; Ewert P; Berger F; Assa S; Schubert S
    Pediatr Cardiol; 2015 Feb; 36(2):379-85. PubMed ID: 25179462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcatheter closure of perimembranous ventricular septal defects with Amplatzer® duct occluder I; The first case report in Japan.
    Fujii T; Higaki T; Tomita H; Nagaoka K; Yamaguchi H; Shimizu T; Oyama N; Sasaki T; Asada D; Hata Y; Tarui S; Miyahara Y; Ishino K; Soga T; Ota M
    J Cardiol Cases; 2019 Oct; 20(4):147-150. PubMed ID: 31969946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The morphologic changes of Amplatzer asymmetric ventricular septal defect occluder after transcatheter closure of perimembrane ventricular septal defect].
    Ma YT; Yang YN; Tang BP; Huang D; Mu YM; Ma X; Liu X
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):817-20. PubMed ID: 15631704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfemoral Perimembranous Ventricular Septal Defect Device Closure in Infants Weighing ≤ 10 kg.
    Alshahrani D; Linnane N; McCrossan B; Oslizlok P; McMahon CJ; Walsh KP; Kenny DP
    Pediatr Cardiol; 2023 Jun; 44(5):1176-1182. PubMed ID: 36698044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter closure of perimembranous ventricular septal defect with the Amplatzer(®) membranous VSD occluder 2: initial world experience and one-year follow-up.
    Tzikas A; Ibrahim R; Velasco-Sanchez D; Freixa X; Alburquenque M; Khairy P; Bass JL; Ramirez J; Aguirre D; Miro J
    Catheter Cardiovasc Interv; 2014 Mar; 83(4):571-80. PubMed ID: 23703890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.